November 24th, 2014
Selections from Richard Lehman’s Literature Review: November 24th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the PROTECT-AF trial, the association of inpatient vs. outpatient onset of STEMI with treatment and clinical outcomes, and more.
September 10th, 2014
FDA Advisory Panel Offers Cautious Support for Polypill
Larry Husten, PHD
The controversial polypill took one step closer to reaching the U.S. market after receiving a mostly positive reception from the FDA’s Cardiovascular and Renal Drugs Advisory Committee on Wednesday. The idea for the polypill– which in this case would be composed of aspirin, a statin, and one or more blood pressure drugs– has been kicking around for […]
October 29th, 2013
Using CAC Scores to Determine the Best Candidates for a Polypill
Anita Vashi, MD, MPH
Khurram Nasir discusses his research group’s JACC study, which examines whether the coronary artery calcium score can be used to determine the target population for a polypill.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?